Last reviewed · How we verify
A Phase II Trial Of Adjuvant Chemoradiation Following Pancreatic Resection For Adenocarcinomas Of The Pancreas Using 3-D Conformal Radiation With Cisplatin, 5FU, And Alpha-Interferon As Radiosensitizing Agents Followed By Gemcitabine
To describe the overall survival and disease-free survival in pancreatic cancer patients treated with adjuvant chemoradiation with cisplatin, continuous infusion 5FU and interferon alpha followed by gemcitabine. To describe the toxicities associated with adjuvant chemoradiation with cisplatin. 5FU and interferon alfa followed by gemcitabine in patients with pancreatic cancers.
Details
| Lead sponsor | Washington University School of Medicine |
|---|---|
| Phase | Phase 2 |
| Status | COMPLETED |
| Enrolment | 53 |
| Start date | 2002-05 |
| Completion | 2009-02 |
Conditions
- Pancreatic Cancer
Interventions
- Pancreatic Surgery
- Radiation therapy
- Cisplatin
- 5-FU
- Alpha-interferon
- Gemcitabine
Primary outcomes
- To describe the overall survival and disease-free survival — 2 years
Countries
United States